Who
Orlando D. Ashford
Director
Company insider
Files Form 4 as: Director, Array Technologies; Director, Perrigo Company; Director, Amerant Bancorp; Director, Itt; SVP, Chief HR & Comm. Officer, Marsh.
In numbers
- Trades disclosed
- 86
- Buys
- 1
- Sells
- 6
- Bought
- $13K
- Sold
- $2.1M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 22 Sep 2008
- Last trade
- 19 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 21 May 2026 | ARRY Array TechnologiesSolar & Renewables | SEC FORM 4 Code M | —22,164 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | ARRY Array Technologiesoption or derivative · Solar & Renewables | SEC FORM 4 Code M | —22,164 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | ARRY Array Technologiesoption or derivative · Solar & Renewables | SEC FORM 4 Code A | —22,641 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | ARRY Array Technologiesoption or derivative · Solar & Renewables | SEC FORM 4 Code M | —22,164 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | ARRY Array Technologiesoption or derivative · Solar & Renewables | SEC FORM 4 Code A | —22,641 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | ARRY Array TechnologiesSolar & Renewables | SEC FORM 4 Code M | —22,164 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $116K10,669 at $10.84 | filing |
| 14 May 2026filed 15 May 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $56K5,122 at $10.84 | filing |
| 14 May 2026filed 15 May 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,669 | filing |
| 14 May 2026filed 15 May 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,669 | filing |
| 14 May 2026filed 15 May 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $116K10,669 at $10.84 | filing |
| 14 May 2026filed 15 May 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $56K5,122 at $10.84 | filing |
| 13 May 2026filed 15 May 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,363 | filing |
| 13 May 2026filed 15 May 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,363 | filing |
| 21 May 2025filed 22 May 2025 | ARRY Array TechnologiesSolar & Renewables | SEC FORM 4 Code A | —15,301 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | ARRY Array Technologiesoption or derivative · Solar & Renewables | SEC FORM 4 Code A | $170K22,164 at $7.67 | filing |
| 14 May 2025filed 16 May 2025 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,669 | filing |
| 14 May 2025filed 16 May 2025 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,380 | filing |
| 14 May 2025filed 16 May 2025 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $322K12,380 at $26.01 | filing |
| 14 May 2025filed 16 May 2025 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $155K5,943 at $26.01 | filing |
News
Financial Review: Marsh & McLennan Companies (NYSE:MRSH) and Intact Financial (OTCMKTS:IFCZF)MRSH · dailypolitical.com · 18 Oct 2026Marsh outlines $600M Thrive savings target through 2028 while reaffirming 2026 underlying growth outlook (NYSE:MRSH)MRSH · seekingalpha.com · 15 Oct 2026Marsh & McLennan Companies (NYSE:MRSH) Stock Sold Off by Rep. Kevin HernMRSH · dailypolitical.com · 15 Oct 2026
0 headlines in the last 90 days name Orlando D. Ashford; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.